Back to Journals » Drug Design, Development and Therapy » Volume 4

Development of a sublingual allergy vaccine for grass pollinosis

Authors Franco Frati, Silvia Scurati, Paola Puccinelli, et al

Published 17 June 2010 Volume 2010:4 Pages 99—105

DOI https://doi.org/10.2147/DDDT.S10044

Review by Single-blind

Peer reviewer comments 2

Franco Frati1,2, Silvia Scurati1, Paola Puccinelli1, Marie David3, Cecile Hilaire4, Maurizio Capecce4, Francesco Marcucci2, Cristoforo Incorvaia5

1Medical and Scientific Department, Stallergenes, Milan, Italy; 2University Department of Medical and Surgical Specialties and Public Health, Perugia, Italy; 3Laboratoire Stallergenes, Antony, France; 4Marketing Department, Stallergenes, Milan, Italy; 5Allergy/Pulmonary Rehabilitation Unit, ICP Hospital, Milan, Italy

Abstract: Grass pollen is a very common cause of allergic rhinitis and asthma. The only treatment targeting the underlying causes of allergy is immunotherapy (IT). Sublingual immunotherapy (SLIT) has been introduced to solve the problem of systemic reactions to subcutaneous IT (SCIT). This article evaluates the characteristics of the allergen extract, Staloral, in terms of practical administration, effectiveness, safety, and mechanism of action. Efficacy data were obtained from double-blind, placebo-controlled studies using Staloral in patients sensitized to grass pollen, while practical administration, cost-effectiveness, and mechanism of action data were provided by well designed studies. The efficacy and safety of Staloral, as demonstrated by review of published studies which used doses up to 1125 times those administered with SCIT, shows that this allergen extract has optimal characteristics for treating patients with seasonal allergies due to grass pollens. The main mechanism of action is the interaction between dendritic cells of the oral mucosa and the subsequent tolerance induced in T-cells.
Keywords: allergen extracts, high-dose, efficacy, safety, sublingual immunotherapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Striving for optimal bronchodilation: focus on olodaterol

Incorvaia C, Montagni M, Makri E, Riario-Sforza GG, Ridolo E

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:439-444

Published Date: 1 March 2016

New combinations in the treatment of COPD: rationale for aclidinium–formoterol

Incorvaia C, Montagni M, Makri E, Ridolo E

Therapeutics and Clinical Risk Management 2016, 12:209-215

Published Date: 15 February 2016

Omalizumab, an anti-immunoglobulin E antibody: state of the art

Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E

Drug Design, Development and Therapy 2014, 8:197-207

Published Date: 7 February 2014

Shrinking the room for invasive ventilation in hypercapnic respiratory failure

Scarpazza P, Incorvaia C, Melacini C, Cattaneo R, Bonacina C, Riario-Sforza GG, Casali W

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:135-137

Published Date: 15 March 2013

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

Frati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P

Drug Design, Development and Therapy 2012, 6:117-123

Published Date: 18 May 2012

Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy

Qualizza R, Incorvaia C, Grande R, Makri E, Allegra L

International Journal of General Medicine 2011, 4:783-787

Published Date: 22 November 2011

Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation

Scarpazza P, Incorvaia C, Amboni P, di Franco G, Raschi S, Usai P, Bernareggi M, Bonacina C, Melacini C, Cattaneo R, Bencini S, Pravettoni C, Riario-Sforza GG, Passalacqua G, Casali W

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:253-257

Published Date: 26 April 2011

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children

Cristoforo Incorvaia, Simonetta Masieri, Silvia Scurati, et al

Journal of Asthma and Allergy 2011, 4:13-17

Published Date: 20 February 2011

Adherence issues related to sublingual immunotherapy as perceived by allergists

Silvia Scurati, Franco Frati, Gianni Passalacqua, et al

Patient Preference and Adherence 2010, 4:141-145

Published Date: 15 June 2010

Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study

Gian Galeazzo Riario-Sforza, Cristoforo Incorvaia, Fulvia Paterniti, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:315-319

Published Date: 21 August 2009

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010